Aqua Medical Secures Series B to Advance Diabetes Trial
Pleasanton, California, U.S., September 24, 2026 Aqua Medical, Inc. has announced the closing of a Series B financing led...
Antimicrobial Therapy
Advertisement
Synergy Spine Solutions Reports Two-Year Synergy Disc Results
Louisville, Colorado, U.S., September 24, 2026 Synergy Spine Solutions has announced the publication of two-year clinical results for its...
Lakewood-Amedex Starts Phase 2a Trial of Nu-3 for Foot Ulcers
San Diego, California, U.S., September 24, 2026 Lakewood-Amedex Biotherapeutics has announced that the first patient has been dosed in...
Intelligent Bio Solutions Completes Clinical Study for FDA 510(k) Submission
NEW YORK, August 11, 2026 Intelligent Bio Solutions Inc. announced the completion of its multi-site Method Comparison Study for...
SNIPR Advances SNIPR001 With Compassionate-Use Clinical Evidence
COPENHAGEN, Denmark, August 12, 2026 SNIPR announced new clinical evidence supporting the translational potential of SNIPR001, its engineered CRISPR-enhanced...
Advertisements
Lakewood-Amedex Advances Nu-3 Gel Toward Phase 2a Trial
SARASOTA, Fla., July 15, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced encouraging preclinical safety results supporting dose selection for the...
Saol Therapeutics Resubmits NDA for SL1009 in PDCD
ROSWELL, Ga., DUBLIN, Ireland & HAMILTON, Bermuda, July 7, 2026 Saol Therapeutics has announced the resubmission of its New...
Lakewood-Amedex Backs PASTEUR Act to Fight AMR Crisis
SARASOTA, Fla., July 7, 2026 Lakewood-Amedex Biotherapeutics has announced its support for the reintroduction of the bipartisan Pioneering Antimicrobial...
Advertisement
